Skip to main content

Search results

90% of our funding comes from individual donors. Learn how you can support MSF’s lifesaving care with a gift.

Scroll down for content
Protesters hold signs protesting Danaher prices as part of the Time for $5 campaign.

Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests

story Mar 22, 2024

News Mar 25, 2024

MSF statement on UN Security Council vote for Gaza ceasefire

Destroyed buildings in Gaza, Palestine on December 12, 2023.

story Mar 21, 2024

To eat or feed my child? A mother’s dilemma in Yemen

Three women carry babies outside Abs General Hospital in Yemen.

story Mar 21, 2024

Remembering our colleagues killed in Gaza

MSF staff killed in Gaza.

story Mar 22, 2024

Five key questions for an Ebola expert

Ebola: 10 years later - what has changed?

Speaking out about the emergencies our staff and patients witness is part of who we are. Explore our history and principles.

News & stories

38 results

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

Read More
A patient sits at a table in front of an MSF staff member for a free X-ray at an MSF tuberculosis (TB) screening sites in Manila.

Story | Mar 23, 2023

How to end TB: Teach it at school

MSF has developed a TB education curriculum that empowers educators and learners to become TB advocates.

Read More

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

Read More
Mirror of a woman wearing a surgical face mask in Mumbai, India.

News | Dec 21, 2022

MSF trial finds better treatment for people with TB

Results published in the New England Journal of Medicine today show that a much shorter treatment regimen for drug-resistant TB is safer and cured almost 90 percent of patients

Read More
Brian Andrew goes to the MSF TB clinic in Kerema every day to take his medication under supervision. Gulf Province, Papua New Guinea, June 2019.

News | Apr 22, 2022

South Africa: MSF responds to devastating floods as people struggle to access clean water

Read More
Ethekwini Flooding: Flood damage

News | Mar 24, 2022

World TB Day: MSF's community-based project in South Africa informs new global guidance

Children living with TB should be cared for in their communities.

Read More
Nonyanyiso Baloi - MSF Treatment For TB in South Africa.

Story | Dec 01, 2021

World AIDS Day 2021: Bringing care to remote communities in South Africa

Read More

News | Oct 20, 2021

MSF tuberculosis clinical trial finds shorter, more effective, and safer treatment

Read More
An MSF doctor in India looks at an X-ray of a lung.

News | Oct 18, 2021

EndTB clinical trial for multidrug-resistant tuberculosis concludes enrollment

Read More
A child sits between two people in surgical masks after completing TB treatment from MSF in Papua New Guinea.
For Donation Inquiries 
See donor options here
 
U.S. Media Inquiries 

Reach out to the press team
 
Non-U.S. Media Inquiries 

Contact the MSF office in your country/territory.

Support our work where it’s needed most.

Your unrestricted gifts enable us to provide lifesaving medical humanitarian care on the ground and speak out about what we see.